Product Images Rhuzdah

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Rhuzdah NDC 59651-740 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - norethindroneethinyl fig1

Figure 1 - norethindroneethinyl fig1

The text consists of a figure that shows Circulatory Disease Mortality Rates per 100,000 Women-Years categorized by Age, Smoking Status, and Oral Contraceptive Use. The figure presents Mortality Rates for Ever-Users (Non-Smokers & Smokers) and Controls (Non-Smokers & Smokers) across four age groups (15-24, 25-34, 35-44, and 45+). The Mortality Rates range from 0 to 250, and the figure suggests that age, smoking status, and oral contraceptive use are correlated with varying Mortality Rates.*

figure - norethindroneethinyl fig2

figure - norethindroneethinyl fig2

This text presents information on various studies related to the use of contraceptives among women. The studies include NICHD Women's Contraceptive Study, French E3N cohort Study, Shanghai Women's Health Study, The Nurses' Health Study II, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The text provides estimates of effect (OR/RR) for ever use and current use of contraceptives in these studies. The information is presented in a tabular format that includes numeric values and corresponding study names and years.*

figure - norethindroneethinyl fig3

figure - norethindroneethinyl fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -0.4 mg/0.035 mg (28 Tablets Pouch) - norethindroneethinyl fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -0.4 mg/0.035 mg (28 Tablets Pouch) - norethindroneethinyl fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -0.4 mg/0.035 mg (6 x 28 Tablets) - norethindroneethinyl fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -0.4 mg/0.035 mg (6 x 28 Tablets) - norethindroneethinyl fig5

This is a description for oral contraceptive pills with 0.4 mg/0.035 mg strength of norethindrone and ethinyl estradiol tablets, USP. The package contains 6 pouches, and each pouch has 28 tablets. These pills are taken once a day as per the prescription to prevent pregnancy. However, they do not protect against sexually transmitted diseases or HIV/AIDS. Dosage and other information are provided on the package. Please keep the package in a controlled room temperature and out of the reach of children.*

Chemical Structure - norethindroneethinyl str

Chemical Structure - norethindroneethinyl str

This text provides chemical information about two compounds - Norethindrone Ethinyl Estradiol. It includes their molecular formulas and weight. The first line shows the chemical structure of an unknown compound with the formula C=CH.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.